• Overview
  • Eligibility
  • More info
  • Locations

A Randomized Trial Comparing Intaoperative Intravenous Sodium Fluorescein to Pre-Operative Oral Phenazopyridine For Evaluation of Ureteral Patency (NCT02757417)

Megan Billow
Graham Chapman
Sangeeta Mahajan
Alex Soriano
Sherif El-Nashar
To determine the safety profile of sodium fluorescein in women undergoing cystoscopy during gynecologic surgery. To determine if either oral phenazopyridine or sodium fluorescein result in shorter cystoscopy times.
  • Drug: sodium fluorescein
    • Drug: phenazopyridine
      Ages eligible for Study
      18 Years and older
      Genders eligible for Study
      Accepts Healthy Volunteers
      Accepts Healthy Volunteers
      Inclusion Criteria:
      • - Patients must be 18 years or older as well as willing and able to provide informed consent
      • Patients undergoing a scheduled gynecologic procedure with cystoscopy
      Exclusion Criteria:
      • - Patients are younger than 18 years
      • Patients are unable or unwilling to provide informed consent
      • Patients with a history of an allergic reaction to sodium fluorescein or phenazopyridine
      • Patients with a history of renal insufficiency
      • Patients with a history of liver disease
      • Patients with a history of sickle cell disease
      • Patients with a history of glucose-6-phosphate dehydrogenase deficiency
      • Patients with a history of chronic obstructive pulmonary disease or currently being treated for asthma

      1 locations

      United States (1)
      • University Hospitals Cleveland Medical Center
        Cleveland, Ohio, United States, 44106
      30 June, 2016
      04 May, 2017
      A girl giving information about available additional trials.

      FindMeCure helps you find, understand and join clinical trials from all over the world.

      There are more clinical trials for your condition!